Koninklijke Philips NV has announced a new partnership with Anumana, enhancing its ECG ecosystem by integrating third-party AI solutions to support clinical decision-making in cardiac care. Through the Philips ECG AI Marketplace, the collaboration aims to improve access to early cardiovascular disease detection and care by providing cardiac care teams with AI-enabled diagnostic tools. This partnership will enable U.S. hospitals to integrate validated algorithms into their workflow, reducing the time clinicians spend reviewing ECG results and expediting patient diagnoses. Anumana's AI algorithms, including those for LEF detection, have been extensively validated and will be available on Philips' trusted platform, reflecting a commitment to improving outcomes for patients at risk of heart failure.